|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 21.46 USD | +9.77% |
|
+6.19% | - |
| 08-14 | Attovia Therapeutics Insider Bought Shares Worth $10,285,000, According to a Recent SEC Filing | MT |
| 08-05 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to NASDAQ Composite Index | CI |
| 1 day | +9.77% | ||
| 1 week | +6.19% |
| 1 week | 18.85 |  | 21.96 |
| 1 month | 16.15 | | 24.32 |
| Current year | 16.15 | | 24.32 |
| 1 year | 16.15 | | 24.32 |
| 3 years | 16.15 | | 24.32 |
| 5 years | 16.15 | | 24.32 |
| 10 years | 16.15 | | 24.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hangjun Zhan
CTO | Chief Tech/Sci/R&D Officer | - | 2022-12-15 |
Petter Veiby
CTO | Chief Tech/Sci/R&D Officer | 61 | 2023-05-31 |
Tao Fu
CEO | Chief Executive Officer | 54 | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Royston
BRD | Director/Board Member | 42 | 2023-05-31 |
Tao Fu
BRD | Director/Board Member | 54 | 2023-03-31 |
James Topper
CHM | Chairman | 64 | 2023-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/6/26 | Conversion | 1,865,710 | 4.3359% | |||
| 8/6/26 | Deep Track Capital LP
| Conversion | Company | 20,138,956 | 46.8032% | |
| 8/6/26 | Frazier Life Sciences Management LP
| Conversion | Company | 57,086,820 | 132.6705% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.77% | +6.19% | - | - | 923M | |
| +3.31% | -3.70% | +61.03% | +103.64% | 70.64B | |
| +1.09% | +2.51% | +49.34% | +93.39% | 66.11B | |
| -1.03% | +0.46% | +8.14% | -5.28% | 27.98B | |
| -2.41% | -2.95% | -9.77% | +455.82% | 26.51B | |
| +0.59% | -0.29% | +63.82% | +12.38% | 26.44B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 20.4B | |
| +0.37% | +1.21% | +36.55% | -15.78% | 20.17B | |
| -1.81% | -4.18% | +13.55% | +532.52% | 15.99B | |
| -1.50% | +2.92% | +43.50% | +151.30% | 13.69B | |
| Average | +0.96% | +1.51% | +59.51% | +194.26% | 28.89B | |
| Weighted average by Cap. | +0.76% | +0.67% | +56.53% | +154.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.35 1.16 1.08 0.99 1.87 128.94 1.88 12.85 5.02 64.98 5.07 4.96 215.07 |
| Net income | -39.8M -34.17M -31.99M -29.29M -55.17M -3.8B -55.33M -379M -148M -1.92B -149M -146M -6.34B | -60.63M -52.04M -48.72M -44.61M -84.05M -5.79B -84.28M -577M -226M -2.92B -228M -223M -9.66B |
| Net Debt | - | - |
Employees
44
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | US$21.46 | +9.77% | 137,307 |
| 26-08-26 | US$19.55 | +1.24% | 143,299 |
| 26-08-25 | US$19.31 | -6.35% | 189,293 |
| 26-08-24 | US$20.62 | -0.87% | 81,036 |
| 26-08-21 | US$20.80 | +2.92% | 362,171 |
- Stock Market
- Stocks
- ATTO Stock
Select your edition
All financial news and data tailored to specific country editions
